Apoptosis Biochemical Screening and Profiling

IntroductionPlatformTarget CoverageTechniquesSupportContact Us

Introduction

Apoptosis, or programmed cell death, is a fundamental mechanism that maintains homeostasis in multicellular organisms by removing damaged, abnormal, or excess cells. It plays central roles in embryonic development, immune regulation, and tissue homeostasis. Dysregulation of apoptotic pathways is implicated in numerous diseases, including cancer (insufficient apoptosis), neurodegenerative disorders (excessive apoptosis), and autoimmune diseases. Consequently, biochemical studies targeting key nodes of apoptosis pathways are critical for drug discovery and target validation.

Core Biochemical Mechanisms of Apoptosis

Apoptosis is primarily mediated by two highly conserved signaling pathways:

Intrinsic Pathway (Mitochondrial Pathway): Triggered by intracellular stress signals such as DNA damage or oxidative stress, the BCL-2 protein family regulates this pathway. Members of this family regulate mitochondrial outer membrane permeability, determining whether pro-apoptotic factors, such as cytochrome C, are released into the cytosol to initiate the caspase cascade.
Extrinsic Pathway (Death Receptor Pathway): Initiated by extracellular death ligands (e.g., FasL, TNF-α) binding to corresponding transmembrane death receptors, leading to recruitment and activation of initiator caspases and subsequent execution of downstream apoptotic processes.

Apoptosis Biochemical screening and profiling Figure 1. Apoptosis pathways. (Chaudhry GE. et al., 2022.)

Both pathways converge on the activation of caspase family proteases. Caspases act as executioners of apoptosis, and their activation is an irreversible step that cleaves numerous intracellular substrates, resulting in characteristic biochemical and morphological changes.

Creative Biogene's Biochemical Screening and Analysis Platform

Creative Biogene has established a comprehensive biochemical screening and analysis platform for apoptosis research. The platform enables cell-free evaluation of compound interactions with key apoptotic targets and their effects on enzyme activity, providing precise and controllable mechanistic data.

Target Coverage and Service Capabilities

Our platform supports activity analysis and ligand screening for multiple apoptosis-related proteins, including but not limited to:

Category	Representative Targets	Assay Focus
BCL-2 Family	BCL-2, Bcl-xL, Bcl-w, Bax, Bak, Bad, Bid, Bik, Bim, Bmf, MCL-1, Noxa, Puma, Bok	Interaction assays; binding/competition; membrane permeabilization
Caspases	Caspase-1, 2, 3, 5, 6, 7, 8, 9, 10	Activity measurement; inhibitor profiling; substrate assays
IAP Family	XIAP, c-IAP1/2, Survivin, Livin, NAIP, BRUCE	Binding assays; SMAC-related competition; regulatory interaction
p53 & Stress Regulators	p53, c-Myc, Mtd	Activity modulation; stability/response assays
TNF/TNFR Superfamily	TNFRSF1A/B, TNFRSF3, 4, 5, 6, 6B, 7, 8, 9, 10A, 10B, 10C, 10D, 11A, 11B, 12A, 13B, 13C, 14, 16, 17, 18, 19, 19L, 21, 25, 27	Ligand–receptor analysis; pathway activation readouts
Neurotrophic Receptors	TrkA, TrkB, TrkC	Receptor binding; phosphorylation/signal output
Survival Signaling Kinases	Akt	Kinase activity; pathway modulation

Detection formats can be customized, including single-point screening, dose-response assays, kinetic monitoring, or comprehensive target profiling, enabling thorough evaluation of compound effects on the apoptosis network.

Key Biochemical Techniques

Time-Resolved FRET Assays: Used for quantitative analysis of protein–protein interactions, such as binding between anti-apoptotic BCL-2 proteins and pro-apoptotic peptides. The format offers high sensitivity, low background, and compatibility with automated high-throughput screening.
Fluorescence Polarization/Anisotropy: Measures binding between small molecules and target proteins or protease activity against fluorescent substrates, supporting high-throughput and competitive binding assays.
Fluorescent/Luminescent Substrate Hydrolysis: Quantifies caspase enzymatic activity directly, allowing evaluation of compound inhibitory potency and calculation of IC₅₀ values.

Comprehensive Support for Target-Based Drug Discovery

Our services provide flexible, reliable support for drug screening and target characterization:

Custom Screening and Characterization

Clients select specific apoptotic targets, and we optimize the most appropriate biochemical assay for each.

Compound Potency Assessment

From single-concentration primary screens to detailed IC₅₀/EC₅₀ measurements, delivering dose-response curves and quantitative efficacy data.

High-Quality Reagents

To facilitate further cellular and in vivo studies, Creative Biogene provides apoptosis research tools, including engineered cell lines, viral particles, and recombinant proteins or lysates.

Contact Us

Through rigorous and reliable biochemical screening and analysis services, Creative Biogene supports foundational research and drug discovery in the fields of apoptosis and related diseases. Clients with specific targets or project needs are encouraged to contact us to discuss customized service solutions.

* For research use only. Not intended for any clinical use.

Quick Inquiry